期刊文献+

中国HIV/AIDS患者tat第一外显子基因变异特点与疾病进展关系的研究

The ralationship between the HIV/AIDS progress and mutation of tat exonl gene
下载PDF
导出
摘要 目的了解中国HIV/AIDS患者tat第一外显子的基因序列的特征和变异特点,探讨其与HIV-1感染者疾病是展之间的关系。方法选取40例辽宁和吉林HIV感染后临床进程不同的人抽取外周血,提取核酸,用套式聚合酶链反应(PCR)扩增HIV-1的tat基因,并进行核酸测序,生成系统进化树。结果长期不进展者、无症状感染者及AIDS患者的tat基因序列与相应亚型的国际流行株序列比较,各组均存在与流行株序列不一致的氨基酸变异,而且某些变异具有组间特异性。在系统树分析中各组聚集在一起,呈混合分布。结论中国HIV/AIDS患者tat第一外显子一些位点的基因变异可能与疾病进展有关,某些位点的基因变异可能会降低病毒的复制能力。 Objective To study the characteristics of human immunodeficiency virus (HIV-1) tat exonl gene mutations among HIV-1 infected people in China.So as to find the ralationship between the tat gene mutation and the disease progression.Methods We extracted PBMC genome DNA from the whole blood samples of HIV-1 carriers and AIDS patients. The gene sequences of the Tat exonl were amplified by nest-polymerase chain reaction (nest-PCR). Products were sequenced directly,the sequences were aligned,translated and analyzed.Results There is difference in sequence variation between China HIV-1 in fected individuals and their according international ones. This difference is also exist among the LINP,asymptomatic HIV-1 infected individuals and AIDS patients.Individuals of three groups distribute together in the phelogenetic tree analysis.Conclusion some of the mutations of tat exonl could increase/decrease the ability of regulation transcription of Tat protein ,so as to increase/decrease the viral replication ability.
出处 《中国实验诊断学》 2006年第1期47-50,共4页 Chinese Journal of Laboratory Diagnosis
关键词 人类免疫缺陷病毒Ⅰ型 TAT基因 变异 亚型 Human immunodeficiency virus tat Mutation Subtype
  • 引文网络
  • 相关文献

参考文献15

  • 1Dingwall C, Ernberg I, Gait MJ, et al. Human immunodeficiency virus 1 Tat protein binds transaetivation-responsive resion(TAR)RNA in vitro[J] .Proe Natl Aead Sci USA,1989,6:6925.
  • 2Dayton A J, JG Sodroski, CA Rosen. The trans-activator gene of the human T-cell lymphotropic virus type Ⅲ is required for replication[J], Cell, 1986,4:941.
  • 3Coffin JM. HIV population dynamics in vivo: Implication for genetic variation, pat hogenesis, and therapy[J]. Science, 1995,267:483.
  • 4Wei X Ghosh, SK Talor, M. E,Johnson, V. A, Emini, E. A. Deutsch.P,Lifson,J. D, et al. Viral dynamics in human immunodeficiency virus type 1 in fection[ J]. Nature, 1995,373-117.
  • 5Pantaleo, G. Menzo, S. et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection[J]. N Engl .J.Med, 1995,332: 209.
  • 6杰尹A利维 著.爱滋病病毒与爱滋病的发病机制[M].第2版[M].北京:科学出版社,2000:1..
  • 7Mayer CD,Seto M, Tateno, A Levy. Biologic features of HIV that correlate with virulence in the host[J] .Science, 1988,240:80.
  • 8Caputo A,Grossi M, Bozzini R,et al. Inhibition of HI V-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region[J]. Gene Ther, 1996,3(3) :235.
  • 9Han P, Brown R, Barsoum J. Transactivation of heterologous promoters by HIV-1 tat[J]. Nucleic Acids Res, 1991,19(25) :7225.
  • 10Balboni PG, Bozzini S, Marconi PC, et al. Inhibition of Human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant[J] .J Med Virol, 1993,41(4):289.
;
使用帮助 返回顶部